Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.05 USD | -9.44% |
|
-5.68% | -18.34% |
Jun. 14 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating | MT |
Jun. 14 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.34% | 3.53B | |
+18.15% | 124B | |
+18.02% | 112B | |
-12.75% | 22.22B | |
+5.07% | 22.94B | |
-39.94% | 16.87B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- Sector Update: Health Care Stocks Gain Pre-Bell Friday